Simvastatin is a methylhydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor primarily used to lower cholesterol levels, specifically total cholesterol, low-density lipoprotein cholesterol (LDL-C), and very low-density lipoprotein cholesterol (VLDL-C).
For patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, or mixed hypercholesterolemia, simvastatin is indicated as an adjunctive therapy to diet when the response to nonpharmacological measures alone is inadequate.
It reduces elevated levels of total cholesterol, LDL-C, apolipoprotein B, and triglycerides.
Simvastatin also increases high-density lipoprotein cholesterol (HDL-C), thereby lowering the LDL-C/HDL-C and total cholesterol/HDL-C ratios.
Safety Information
Risk Phrases: R36/37/38 (Irritating to eyes, respiratory system, and skin)
Safety Statements:
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.